122 related articles for article (PubMed ID: 21183892)
21. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk.
Ukimura O; Kawauchi A; Fujito A; Mizutani Y; Okihara K; Mikami K; Soh J; Nakamura T; Nakanishi H; Ushijima S; Miki T
Int J Urol; 2004 Dec; 11(12):1051-7. PubMed ID: 15663674
[TBL] [Abstract][Full Text] [Related]
22. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation.
Hegarty NJ; Gill IS; Desai MM; Remer EM; O'Malley CM; Kaouk JH
Urology; 2006 Jul; 68(1 Suppl):7-13. PubMed ID: 16857454
[TBL] [Abstract][Full Text] [Related]
23. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
24. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
25. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.
Kunkle DA; Egleston BL; Uzzo RG
J Urol; 2008 Apr; 179(4):1227-33; discussion 1233-4. PubMed ID: 18280512
[TBL] [Abstract][Full Text] [Related]
26. The current management of small renal masses.
Trinh QD; Saad F; Lattouf JB
Curr Opin Support Palliat Care; 2009 Sep; 3(3):180-5. PubMed ID: 19553818
[TBL] [Abstract][Full Text] [Related]
27. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
28. Cryotherapy: clinical end points and their experimental foundations.
Kaouk JH; Aron M; Rewcastle JC; Gill IS
Urology; 2006 Jul; 68(1 Suppl):38-44. PubMed ID: 16857458
[TBL] [Abstract][Full Text] [Related]
29. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review.
Johnson DB; Solomon SB; Su LM; Matsumoto ED; Kavoussi LR; Nakada SY; Moon TD; Shingleton WB; Cadeddu JA
J Urol; 2004 Sep; 172(3):874-7. PubMed ID: 15310987
[TBL] [Abstract][Full Text] [Related]
30. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation.
Svatek RS; Sims R; Anderson JK; Abdel-Aziz K; Cadeddu JA
Urology; 2006 Mar; 67(3):508-12. PubMed ID: 16504265
[TBL] [Abstract][Full Text] [Related]
32. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates.
Hui GC; Tuncali K; Tatli S; Morrison PR; Silverman SG
J Vasc Interv Radiol; 2008 Sep; 19(9):1311-20. PubMed ID: 18725094
[TBL] [Abstract][Full Text] [Related]
33. Thermal versus impedance-based ablation of renal cell carcinoma: a meta-analysis.
Modabber M; Martin J; Athreya S
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):176-85. PubMed ID: 24091755
[TBL] [Abstract][Full Text] [Related]
34. [Percutaneous radio frequency thermal ablation of non-resectable lung cancer: state of the art].
Monaco M; Scisca C; Pavia R; Sibilio M; La Rocca A; Familiari D; Pavone A; Surleti S; Monaco F; Mondello B
G Chir; 2006 Mar; 27(3):113-8. PubMed ID: 16681873
[TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature.
Garrean S; Hering J; Saied A; Helton WS; Espat NJ
Am J Surg; 2008 Apr; 195(4):508-20. PubMed ID: 18361927
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation of a pancreatic metastasis from renal cell carcinoma: case report.
Carrafiello G; Laganà D; Recaldini C; Dionigi G; Boni L; Bacuzzi A; Fugazzola C
Surg Laparosc Endosc Percutan Tech; 2008 Feb; 18(1):64-6. PubMed ID: 18287986
[TBL] [Abstract][Full Text] [Related]
38. Nephron-sparing probe ablative therapy: long-term outcomes.
Matin SF; Ahrar K
Curr Opin Urol; 2008 Mar; 18(2):150-6. PubMed ID: 18303535
[TBL] [Abstract][Full Text] [Related]
39. Is radiofrequency ablation safe for solitary kidneys?
Jacobsohn KM; Ahrar K; Wood CG; Matin SF
Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
[TBL] [Abstract][Full Text] [Related]
40. Renal thermal ablative therapy.
Sterrett SP; Nakada SY; Wingo MS; Williams SK; Leveillee RJ
Urol Clin North Am; 2008 Aug; 35(3):397-414, viii. PubMed ID: 18761195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
